References
- Advisory Council on the Misuse of Drugs (2000). Reducing Drug Related Deaths, Home Office Report. London: Stationery Office.
- Bewley, T., & Ghodse, A. H. (1983). Unacceptable face of private practice: prescription of controlled drugs to addicts. British Medical Journal, 286, 1876–1877.
- Capelhorn, J. R., & Bell, J. (1991). Methadone dosage and retention of patients in maintenance treatment. Medical Journal of Australia, 154, 195–199.
- De Wet, C., Reed, L. J., & Bearn, J. (2005). The rise of buprenorphine in England. Addiction, 100, 495–499.
- Department of Health (1996). The task force to review services for drug misusers: Report of an independent review of drug treatment services in England. London: Stationary Office.
- Department of Health (2007). Drug misuse and dependence – guidelines on clinical management. London: Stationary Office.
- Dunn, J. (2003). A survey of methadone prescribing at an inner city drug service. Psychiatric Bulletin, 27, 167–170.
- Farre, M., Mas, A., Torren, M., Morno, V., & Cmai, J. (2002). Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug & Alcohol Dependence, 65, 283–290.
- Ford, C., Morton, S., & Lintzeris, N. (2003). Guidance for the use of burprenorphine for the treatment of opioid dependence in primary care. London: Royal College of General Practitioners.
- Ghodse, H., Schizfano, F., Oyefeso, A., Bannister, D., Cobain, K., Dryden, R., & Corkery, J. (2004). Drug-related deaths as reported by participating procurator fiscal and coroners, International Centre for Drug Policy Report 13. London: St George's Hospital Medical School.
- Griffiths, R. R., & Weerts, E. M. (1997). Benzodiazepine self-administration in humans and laboratory animals – implications for problems of long term use and abuse. Psychopharmacology, 134, 1–37.
- Johnson, R. E., Chutupe, M. A., Strain, E. C., Walsh, S. L., Sitizer, M. L., & Bigelow, G. E. (2000). A comparison of levomethadyl acetate, buprenorphine and methadone for opioid dependence. New England Journal of Medicine, 343, 1290–1297.
- Joseph, R., & Moselhy, H. F. (2005). A national survey of methadone prescribing for maintenance treatment. Psychiatric Bulletin, 29, 459–461.
- Ling, W., Wesson, D. R., Charuvastra, C., & Klett, C. J. (1996). A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry, 53, 401–407.
- Lintzeris, N., Ritter, A., Panjani, M., Clark, N., Kutin, J., & Bammer, G. (2003). Implementing buprenorphine treatment in community settings in Australia: experience for the Buprenorphine Implementation Trial. American Journal of Addictions, 13, S29–S41.
- Luty, J. S. (2002). Substance misuse services waiting times and treatment of opiate dependence in Britain. Psychiatric Bulletin, 26, 447–448.
- Luty, J. S. (2004). Treatment preferences of opiate dependent clients. Psychiatric Bulletin, 28, 47–50.
- Luty, J. S. (2005). New guidelines for prescribing injectable heroin in opiate addiction. Psychiatric Bulletin, 29, 123–125.
- Metrebian, N., Shanahan, W., & Stimson, G. V. (1996). Heroin prescribing in the United Kingdom: An overview. European Addiction Research, 2, 194–200.
- National Consensus Development Panel (1998). Effective medical treatment of opiate addiction. Journal of the American Medical Association, 280, 1936–1943.
- National Treatment Agency for Substance Misuse (2003). Injectable heroin (and injectable methadone): potential roles in drug treatment. June 6, 2009, www.nta.nhs.uk.
- Royal College of Psychiatrists (2000). Drug: Dilemmas and choices. London: Gaskell.
- Royal College of Psychiatrists (2002) Annual Census of Psychiatric Staffing 2001, Occasional Paper OP54. London: Gaskell.
- SCODA. (1998). Drug problems: Where to get help. London: Standing Conference on Drug Abuse.
- Strain, E. C., Bigelow, G. E., Liebson, I. A., & Stitzer, M. L. (1999). Moderate- vs high-dose methadone: A randomised trial. Journal of the American Medical Association, 281, 1000–1005.
- Strang, J., & Sheridan, J. (1998). Effect of government recommendations on methadone prescribing in south east England: Comparison of 1995 and 1997 surveys. British Medical Journal, 317, 1489–1490.
- Strang, J., & Sheridan, J. (2001). Methadone prescribing to opiate addicts by private doctors: Comparison with NHS practice in south east England. Addiction, 96, 567–576.
- Taikato, M., Kidd, B., & Baldacchino, A. (2005). What every psychiatrist should know about burprenorphine in substance misuse. Psychiatric Bulletin, 29, 225–227.
- Tait, L., & Lester, H. (2005). Encouraging user involvement in mental health services. Advances in Psychiatric Treatment, 11, 168–175.
- Ward, J., Hall, W., & Mattick, R. P. (1999). Role of maintenance treatment in opioid dependence. Lancet, 353, 221–226.